This contract involves the supply of a pharmaceutical product with the International Nonproprietary Name (INN) Burosumab, at a concentration of 30 mg/ml. This product is included in the list under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products. The contract is published on the
Contract awarded. Originally published 1 years ago.
No single supplier dominates the field.
In healthcare medical, Specialized Hospital for Active Treatment of Pediatric Diseases - Prof. Ivan Mitev EAD has awarded 11 contracts to 9 suppliers.
+3 more suppliers
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the delivery of the medicinal product Calcium Folinate, which is not authorized for use in Bulgaria. The procurement is conducted in accordance with Regulation No. 10/17.11.2011 of the Ministry of Health. The total value of the contract is €12,148.30. The buyer is the Speciali
This contract involves the supply of the medication Guanfacine, which is listed under Article 266a, paragraph 2 of the Law on Medicinal Products in Human Medicine. The procurement follows the guidelines set forth in Regulation No. 10 dated November 17, 2011, by the Ministry of Health. The total valu
This contract involves the supply of a pharmaceutical product with the International Nonproprietary Name (INN) Entecavir. The product is listed under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products. The total value of the contract is €40,742.55. The buyer is the Specialized Hosp
This contract involves the supply of the pharmaceutical product Sepiapterin, which is listed under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products in Human Medicine. The contract is valued at approximately €371,962.17 and is intended for the Specialized Hospital for Active Treat
Apply for up to £500,000 to establish the Medicines Manufacturing Data Institute, a trusted data hub for the medicines ecosystem, with potential for up to £5 million phase 2 funding.
BSO PaLS is seeking supplier feedback through a market engagement survey for intubating devices to inform an upcoming public procurement for Northern Ireland's health and social care sector.
The procurement for integrated healthcare services in Norfolk prisons and liaison and diversion services in Norfolk and Suffolk has been abandoned with no contract awarded.
HSE invites qualified providers to deliver dental treatment services for special needs patients under general anaesthesia in Dublin and South East regions, with two service delivery model options available.
